Debt-to-equity in % of EAGLE PHARMACEUTICALS, INC. from Q3 2020 to Q2 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: EAGLE PHARMACEUTICALS, INC. quarterly Debt-to-equity history and change rate from Q3 2020 to Q2 2023.
EAGLE PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Jun 2023 was 68%, a 40% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

EAGLE PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q2 2023	68%	+19%	+40%	30 Jun 2023
Q1 2023	68%	+26%	+63%	31 Mar 2023
Q4 2022	63%	+24%	+63%	31 Dec 2022
Q3 2022	56%	+19%	+52%	30 Sep 2022
Q2 2022	49%	+11%	+29%	30 Jun 2022
Q1 2022	42%	+2.9%	+7.6%	31 Mar 2022
Q4 2021	38%	-16%	-30%	31 Dec 2021
Q3 2021	37%	-20%	-35%	30 Sep 2021
Q2 2021	38%			30 Jun 2021
Q1 2021	39%			31 Mar 2021
Q4 2020	55%			31 Dec 2020
Q3 2020	56%			30 Sep 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.